Gueyffier F, Gallet M, Chapon P, Coquelin H
Unité 60, hôpital cardiologique, Lyon.
Arch Mal Coeur Vaiss. 1991 Oct;84(10):1413-8.
This study evaluated the time for a new, rapid and reliable CK-MB analysis to become positive in myocardial infarction and compared it with classical total CK analyses. Serial analyses of total CK and CK-MB were performed in 49 consecutive patients referred to the Coronary Care Unit for suspected acute myocardial infarction. Twenty of these patients had myocardial infarction with rising enzyme levels, which enabled comparison of the precocity of one analysis compared to another. In these patients, the CK-MB analysis became positive on average 85 to 110 minutes before that of total CK. This result shows that CK-MB analysis can be a diagnostic sign of acute myocardial infarction at an earlier stage than the total CK analysis. The authors discuss the clinical value of this test in difficult indications of fibrinolytic therapy and underline that it enables a more objective assessment of the time of onset of necrosis than clinical data alone.
本研究评估了一种新型、快速且可靠的肌酸激酶同工酶(CK-MB)分析在心肌梗死中呈阳性的时间,并将其与传统的总肌酸激酶(CK)分析进行比较。对49例因疑似急性心肌梗死被收入冠心病监护病房的连续患者进行了总CK和CK-MB的系列分析。其中20例患者发生心肌梗死且酶水平升高,这使得能够比较一种分析与另一种分析的早熟情况。在这些患者中,CK-MB分析平均比总CK分析提前85至110分钟呈阳性。该结果表明,CK-MB分析可比总CK分析更早地作为急性心肌梗死的诊断指标。作者讨论了该检测在溶栓治疗困难指征中的临床价值,并强调它比单纯临床数据能更客观地评估坏死开始时间。